Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADORA2A | P29274 | 1/20 | 0.44 |
| ▸ | ADORA1 | P30542 | 1/20 | 0.44 |
| ▸ | ACHE | P22303 | 7/20 | 0.40 |
| ▸ | BCHE | P06276 | 1/20 | 0.40 |
| ▸ | KDR | P35968 | 2/20 | 0.38 |
| ▸ | SQOR | Q9Y6N5 | 1/20 | 0.38 |
| ▸ | PNMT | P11086 | 1/20 | 0.35 |
| ▸ | MAP3K9 | P80192 | 1/20 | 0.35 |
| ▸ | MAP3K11 | Q16584 | 1/20 | 0.35 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | RAB9A | P51151 | 1/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29177882 | 0.84 | ADORA2A (0.44) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL27927828 | 0.83 | ADORA2A (0.49) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL28305768 | 0.82 | ADORA2A (0.47) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL8031980 | 0.80 | ADORA2A (0.49) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL21925182 | 0.78 | ACHE (0.41) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL29177879 | 0.77 | ADORA2A (0.49) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL29730500 | 0.76 | MAP3K9 (0.46) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL28145785 | 0.76 | MAP3K9 (0.46) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL31123421 | 0.76 | MAP3K9 (0.46) | ADORA2AADORA1ACHEBCHEKDR | |
| SCHEMBL27965525 | 0.76 | MAP3K9 (0.42) | ADORA2AADORA1ACHEBCHEKDR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230242702-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | ROQUETTE FRERES (FR) | 2023-08-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230242702-A1 | METHOD FOR OBTAINING BIOSOURCED POLYEPOXIDES WITH IMPROVED PROPERTIES | EPHX2, EPHX1, TET3 | ADORA2A 2697/4885ADORA1 2475/4885ACHE 647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.